Market Cap (In USD)
6.48 Million
Revenue (In USD)
-
Net Income (In USD)
-30.86 Million
Avg. Volume
3.98 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.281-14.4
- PE
- -0.05
- EPS
- -5.34
- Beta Value
- -1.286
- ISIN
- US3724462037
- CUSIP
- 372446104
- CIK
- 1595248
- Shares
- 24152800.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ryan M. Confer M.S.
- Employee Count
- -
- Website
- https://www.genprex.com
- Ipo Date
- 2018-03-29
- Details
- Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
More Stocks
-
DHIL
-
300167Shenzhen Division Co.,Ltd.
300167
-
STH
-
NESCONesco Limited
NESCO
-
002348
-
SPITZE
-
BOY
-
LINLinde plc
LIN